PELLUCID MARGINAL CORNEAL DEGENERATION
Clinical trials for PELLUCID MARGINAL CORNEAL DEGENERATION explained in plain language.
Never miss a new study
Get alerted when new PELLUCID MARGINAL CORNEAL DEGENERATION trials appear
Sign up with your email to follow new studies for PELLUCID MARGINAL CORNEAL DEGENERATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New eye treatment aims to halt worsening vision
Disease control Recruiting nowThis study is testing a new medical device called the PXL-Platinum 330 system. It uses a special light treatment called corneal cross-linking to try to stop progressive thinning and bulging of the cornea in conditions like keratoconus. Researchers will enroll 500 patients aged 10…
Matched conditions: PELLUCID MARGINAL CORNEAL DEGENERATION
Phase: PHASE2 • Sponsor: Goodman Eye Center • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC
-
Shorter light treatment for blurry vision disease put to the test
Disease control Recruiting nowThis study is testing if a shorter 18-minute ultraviolet light treatment works as well as the standard 24-minute treatment to stop the progression of certain eye diseases that cause the clear front of the eye (cornea) to thin and bulge, leading to blurred vision. The treatment, c…
Matched conditions: PELLUCID MARGINAL CORNEAL DEGENERATION
Phase: PHASE3 • Sponsor: Woolfson Eye Institute • Aim: Disease control
Last updated Mar 12, 2026 13:52 UTC